Revised SPCs: MabThera (rituximab) concentrate for solution for infusion – all strengths

SPCs updated with guidance for a new indication; rituximab with chemotherapy for treatment of children aged 6 months to 18 yrs with previously untreated advanced CD20 positive diffuse large B-cell lymphoma, Burkitt lymphoma/Burkitt leukaemia/Burkitt-like lymphoma.

electronic Medicines compendium